<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03259256</url>
  </required_header>
  <id_info>
    <org_study_id>Y-03</org_study_id>
    <nct_id>NCT03259256</nct_id>
  </id_info>
  <brief_title>Islet Allotransplantation for Type 1 Diabetic Patients</brief_title>
  <official_title>Islet Allotransplantation for Type 1 Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital of Guangzhou Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if islet cell transplantation , is an effective
      treatment for type 1 diabetes. Study participants may receive up to three islet transplants
      and will be followed for five years to monitor blood sugar control, islet transplant
      function, and changes in quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Obtaining an improvement in glycemic control</measure>
    <time_frame>nine months after first and last islet transplants</time_frame>
    <description>The proportion of subjects with an HbA1c â‰¤ 6.5% and free of severe hypoglycemic events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>normal glycemic control without insulin</measure>
    <time_frame>3 months after graf</time_frame>
    <description>A fasting glucose (&gt; 8 hours) less than 1.25 g/L and a 2 hours glucose after oral intake of 75g of glucose, less than 2 g/L in a patient without insulin for at least 15 consecutive days during the the first 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>insulin independence</measure>
    <time_frame>One year after the last transplant</time_frame>
    <description>insulin independence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemic episodes by HYPO score</measure>
    <time_frame>3 months after transplantation</time_frame>
    <description>Hypoglycemic episodes by HYPO score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>degenerative complications of diabetes</measure>
    <time_frame>18 months after transplantation</time_frame>
    <description>degenerative complications of diabetes</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Type 1 Diabetic</condition>
  <arm_group>
    <arm_group_label>Allogeneic transplantation of human islet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each subject may receive 1-3 transplantations of allogeneic human islets we will inject the least dose of 3,000 IEQ/kg body weight of the recipient. Tacrolimus 1 mg p.o. bid adjusted to reach target trough levels of 3-6 ng/ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Allogeneic transplantation of intrahepatic islet</intervention_name>
    <description>Allogeneic transplantation of intrahepatic islet is one of the effective methods for diabetic therapy</description>
    <arm_group_label>Allogeneic transplantation of human islet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical diagnosis of type 1 diabetes 18 &lt;Age &lt;70 years Evolution of diabetes for more than
        5 years Regular patient follow-up (&gt; or equal to 2 visits per year from the same
        diabetologist) ABO compatibility with the donor Cross match negative Anti-HLA antibodies
        (class I and / or class II) detected by lymphocytotoxicity &lt;20% Accepting patients
        effective contraception during the study period

        Exclusion Criteria:

        Clinical diagnosis of type 2 diabetes BMI &gt; 28 Need insulin &lt; 28 U per day Pregnancy,
        lactation Psychiatric Disorders Inability to communicate or cooperate with the investigator
        Lack of therapeutic compliance, including HbA1C &gt; 12% Chronic liver disease Proliferative
        retinopathy unstabilized History of cancer, whatever the date, except for basal or squamous
        cell skin cancers over 1 year.

        Systemic infection Chronic high risk of requiring corticosteroids Need for long-term
        corticosteroid, outside that specified in renal transplantation, the patients will be
        weaned before transplantation Anticoagulant vitamin K or antiplatelet treatments Platelets
        &lt; 100 giga/L and/or neutrophils &lt;1.5 giga/L Chronic intoxication by alcohol, tobacco, or
        other substance (abstinence &gt; 6 months required) Active infection by hepatitis B, hepatitis
        C and HIV, HTLV-1-HTLV2 Ascites
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ping Xue, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital of Guangzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ping Xue, PhD</last_name>
    <phone>0086-020-34153080</phone>
    <email>gyeygdwk@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>xiaofeng Jiang, MD</last_name>
    <phone>0086-020-34153080</phone>
    <email>gyeygdwk@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510260</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ping Xue, PhD</last_name>
      <phone>+86-020-34153080</phone>
      <email>gyeygdwk@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2017</study_first_submitted>
  <study_first_submitted_qc>August 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>September 24, 2017</last_update_submitted>
  <last_update_submitted_qc>September 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

